Abstract:Background and purpose: MORC2 (microrchidia family CW-type zinc finger 2, MORC2) is a newly identified chromatin remodeling protein that plays key roles in DNA-based biological processes including gene transcription and DNA damage repair. However, its functional role in breast cancer development and progression re-mains unknown. ALDH1A3 (aldehyde dehydrogenase 1 family member A3), a member of the aldehyde dehydrogenases (ALDH) superfamily, is a putative breast cancer stem cell marker, but its regulatory mechanism in breast cancer is poor-ly characterized. This study aimed to investigate the effects of knockdown of endogenous MORC2 on the expression levels of ALDH1A3 and the breast cancer stem-like phenotype in MCF-7 cells. Methods: Human breast cancer MCF-7 cells were infected with negative control short hairpin RNAs (shNC) and specific shRNAs targeting human MORC2 (shMORC2), followed by selection with puromycin to generate stable MORC2 gene knockdown cell lines. Western blot and real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) were used to examine the protein and mRNA levels of ALDH1A3 in MCF-7 cells stably expressing shNC and shMORC2. Microsphere formation and fluo-rescence-activated cell sorting (FACS) assays were used to analyze the effects of knockdown of MORC2 on the breast cancer stem-like phenotype. Results: Western blot and RTFQ-PCR analyses revealed that the protein and mRNA levels of ALDH1A3 were significantly down-regulated in shMORC2 expressing cells as compared with shNC -transfected control cells. Moreover, mammosphere formation assay showed that knockdown of endogenous MORC2 in MCF-7 cells significantly reduced the ability of cells to form microspheres. Consistently, FACS assays demonstrated that shMORC2-transfected cells had a lower proportion of ALDH-positive stem cells as compared with shNC expressing cells. In contrast, knockdown of MORC2 did not significantly affect the CD44+CD24- stem cell population. Conclusion:MORC2 promotes a breast cancer stem-like phenotype through, at least in part, regulating ALDH1A3 expression.

The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis

MORC protein family-related signature within human disease and cancer

The MORC Family

The MORC Family: New Epigenetic Regulators of Transcription and DNA Damage Response.

Oncogenic MORC2 in cancer development and beyond

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer

MORC1 Represses Transposable Elements in the Mouse Male Germline.

Mouse MORC3 is a GHKL ATPase That Localizes to H3K4me3 Marked Chromatin

Arabidopsis AtMORC4 and AtMORC7 Form Nuclear Bodies and Repress a Large Number of Protein-Coding Genes.

MORC proteins regulate transcription factor binding by mediating chromatin compaction in active chromatin regions

Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.

MORC2B is Essential for Meiotic Progression and Fertility

Inhibition of MORC2 Mediates HDAC4 to Promote Cellular Senescence through p53/p21 Signaling Axis

Emerging roles of the chromatin remodeler MORC2 in cancer metabolism

MORC2 Signaling Integrates Phosphorylation-Dependent, ATPase-coupled Chromatin Remodeling During the DNA Damage Response.

Chromatin remodeling protein MORC2 promotes a breast cancer stem-like phenotype by regulating ALDH1A3 expression

Cancer-Associated MORC2-Mutant M276I Regulates an Hnrnpm-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer

MORC2 Regulates DNA Damage Response Through a PARP1-dependent Pathway.

Dimerization of MORC2 Through Its C-terminal Coiled-Coil Domain Enhances Chromatin Dynamics and Promotes DNA Repair

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression